COMMUNIQUÉS West-GlobeNewswire

EssilorLuxottica and Applied Materials Join Forces to Advance Augmented Reality Optics Platforms for Next-Generation Smart Glasses
16/06/2026
EssilorLuxottica and Applied Materials Join Forces to Advance Augmented Reality Optics Platforms for Next-Generation Smart Glasses Joint development agreement aims to accelerate commercialization of next-generation [...]
UBC MOSAIC and LifeLabs Unlock New Ways to Manage and Predict Heart Health
16/06/2026
Toronto, Ontario, June 16, 2026 (GLOBE NEWSWIRE) -- The University of British Columbia MOSAIC research team and LifeLabs have partnered on an initiative that transforms how we understand and manage cardiovascular health [...]
Comprehensive Healthcare implements ZING® robot for methadone dosing
16/06/2026
Robotic methadone dosing assembly system allows for faster client service YAKIMA, Wash., June 16, 2026 (GLOBE NEWSWIRE) -- Comprehensive Healthcare has successfully implemented ZING®, a robotic methadone dosing assembly [...]
KFSH Highlights Innovation Infrastructure as the Foundation for Sustainable Healthcare Transformation at HLTH Europe 2026
16/06/2026
AMSTERDAM, June 16, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSH) is building on its participation at HLTH Europe 2026, taking place from June 15 to 18 in Amsterdam, to highlight [...]
Le KFSH met en avant une infrastructure d’innovation comme socle de la transformation évolutive des soins de santé au salon HLTH Europe 2026
16/06/2026
AMSTERDAM, 16 juin 2026 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre (KFSH) profite de sa participation au HLTH Europe 2026, du 15 au 18 juin à Amsterdam, pour mettre en avant le fait que [...]
FDA Broadens Access to Over-the-Counter Naloxone Nasal Spray for Opioid Overdose
16/06/2026
Silver Spring, MD, June 16, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration (FDA) today approved another over-the-counter (OTC) intranasal naloxone product, Rextovy, a 4 milligram (mg) naloxone [...]
EssilorLuxottica et Applied Materials s’unissent pour faire progresser les dispositifs optiques de réalité augmentée destinés aux nouvelles générations de lunettes intelligentes
16/06/2026
EssilorLuxottica et Applied Materials s’unissent pour faire progresser les dispositifs optiques de réalité augmentée destinés aux nouvelles générations de lunettes intelligentes L'accord de développement conjoint vise à [...]
Sharecare selected by Georgia Department of Community Health to advance rural health transformation through GREAT Health Program
16/06/2026
Company’s next-generation digital health experience, AskMD, to help Georgians better understand health risks, improve outcomes, and foster long-term well-being ATLANTA, June 16, 2026 (GLOBE NEWSWIRE) -- Sharecare, the [...]
Oncolytics Biotech® Secures New U.S. Patent Protecting Commercial Manufacturing of Pelareorep into 2044
16/06/2026
Intellectual property update confirms pelareorep’s unique manufacturing process and scalability Previously filed method-of-use patent application expected to provide protection into 2046 Additional patent filings [...]
Erdem Hospital Highlights Emotional Wellbeing as Part of Patient Care with London Wellness Event
16/06/2026
The free London gathering reflects Erdem Hospital’s belief that recovery is more than physical, with guided breathing, gentle movement, and human connection playing an important role in the patient’s journey ISTANBUL, [...]
Trinity Biotech Awarded Significant Orders for Over 2 Million TrinScreen HIV Tests And Reports Q1 2026 Financial Results
16/06/2026
– Orders reinforce strong demand outlook in global health markets and supports 2026 revenue and profitability targets – Company publishes Q1 2026 financial results with revenue in line with prior guidance & [...]
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
16/06/2026
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 16 June 2026 at 16.00 EEST Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]
FibroBiologics Advances Patient Dosing for Phase 1/2 Clinical Trial of CYWC628 for the Treatment of Diabetic Foot Ulcers
16/06/2026
Company continues to advance CYWC628 manufacturing with second GMP drug product run released for shipment to Australia and a third run nearing completion HOUSTON, June 16, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. ( [...]
Pycnogenol® Brings a “Less-is-More” Approach to the Women’s Health Stack
16/06/2026
Clinically studied French maritime pine bark extract supports skin, circulation, menopause wellness and mobility in one multifunctional ingredient GENEVA, June 16, 2026 (GLOBE NEWSWIRE) -- From hydration and collagen [...]
Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research
16/06/2026
Two naturally derived finished drug products, at 1mg and 2mg, give research organizations the consistent, validated doses required for controlled studies New microdose formats extend Optimi's psilocybin range, which [...]
Nexalin Technology Announces Two Clinical Abstracts Accepted for Presentation at the 2026 NYC Neuromodulation Conference Highlighting Preliminary Clinical Results Across Anxiety, Depression, Insomnia and Quality of Life
16/06/2026
Accepted abstracts showcase Nexalin’s proprietary DIFS™ 15 mA 77.5 Hz treatment platform and clinical improvements across anxiety, depression, insomnia and quality of life Data to be presented include 77.8% anxiety [...]
NewGen Eliminates Convertible Note and Warrant Overhang with a Significant Investor, Enters Into Settlement Agreement Strengthening Capital Structure
16/06/2026
NewGen to repurchase all outstanding convertible notes and warrants previously held by a significant investor in move to strengthen its capital structure Settlement to eliminate potential dilution from convertible notes [...]
GHK-Cu For Sale At Koi Peptides for Laboratory Use in 2026
16/06/2026
SHERIDAN, WY, June 16, 2026 (GLOBE NEWSWIRE) -- Koi Peptides has launched GHK-Cu, the copper tripeptide-1 complex that forms when copper(II) binds glycyl-L-histidyl-L-lysine (a tripeptide), as a research-use-only [...]
Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry
16/06/2026
Interference Study designed to validate system specificity in the presence of potentially interfering substances commonly encountered in real-world settings Company expects to complete the study by mid-July 2026, with [...]

Pages